Novel Tech Ethics
NTE Team
Genetic
Justice
healthpolicy
Events, Jobs, Grants
Opportunities
Opportunites Navigation
» Our Team
» States of Mind
» Reports
» Past Research
» Publications
» Posters
» Brain Mattters
» Conference Sponsors
» Conference Program
» Podcast - J.L. Bernat
» Podcast - W. Glannon
» Podcast - D. Healy
» Podcast - N. Levy
» Podcast - J.H. Marks
» Podcast - C. Tait
» Podcast - J.S. Robert
» Posters
» Resources
» Events Calendar
» Neuro Home Test***
» Photo Gallery
Neuro » Brain Mattters » Podcast - D. Healy

David Healy

Professor of Psychiatry
Cardiff University, Wales, UK 
Visit Dr. Healy's home page

Bioethical Devils and Neuroscientific Details
In the late 1990s, treatments like Prozac and research on the human genome project appeared to usher in a new human reality with associated bioethical dilemmas. Are bioethicists as likely to be co-opted into the marketing of the new neuroscience and its treatments as they were into the marketing of the SSRIs?
Contrasting current neuroimaging with quantitative electroencephalography, recent deep brain stimulation treatments with the brain stimulation treatments run in Tulane in the 1960s, the emergence biofeedback in the 1960s and neurofeedback this decade this paper will attempt pinpoint the dynamics shaping what happens. Using LSD, ECT and apotemnophilia it will also attempt to mark out the boundaries within which any debate is constrained

Click on the below to view the full presentation.

This div will be replaced

   
Quick Links
 
» Member Login
» Contact Us
 
©2006 Novel Tech Ethics.